| abstract |
The present application provides an RNA delivery system for the treatment of glioblastoma. The system includes a viral vector carrying RNA fragments capable of treating glioblastoma, which viral vector is capable of enriching in and endogenously spontaneously endogenous in the host's organ tissue A composite structure containing the RNA fragments capable of treating glioblastoma is formed, and the composite structure is capable of delivering the RNA fragments into the brain to achieve the treatment of glioblastoma. The safety and reliability of the RNA delivery system provided by the present application have been fully verified, and the drugability is very good, the versatility is strong, and it has excellent economic benefits and application prospects. |